Houston (1)

Gastric Cancer (1)

Metastatic Esophageal (1)

Metastatic HPV Related Solid Tumors (1)

Metastatic Head and Neck Carcinoma (1)

Metastatic Hepatocellular Carcinoma (1)

Metastatic Ovarian Carcinoma (1)

Metastatic Soft Tissue Sarcoma (1)

Metastatic Uveal Melanoma (1)

Recruiting (1)

phase 1 (1)

M.D. Anderson Cancer Center (1)

Lyvgen Biopharma Holdings Limited (1)

lvgn3616 + lvgn6051 + bevacizumab + cyclophosphamide (1)

lvgn3616 + lvgn6051 + lvgn7409 + bevacizumab + cyclophosphamide (1)

lvgn3616 + lvgn6051 + lvgn7409 + nab-paclitaxel (1)

lvgn3616 + lvgn6051 + nab-paclitaxel (1)

drug (1)

Other (1)

Interventional (1)

metastatic esophageal

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jul 31, 2022